Device
Active tPCS
Active tPCS is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
2
67%
Ph phase_1
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(2)
Other(1)
Detailed Status
Completed2
unknown1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 1
Trials by Phase
Phase 11 (33.3%)
N/A2 (66.7%)
Trials by Status
unknown133%
completed267%
Recent Activity
0 active trials
Showing 3 of 3
completedphase_1
Neurophysiological Effects of tPCS and tDCS on Patients With Disorders of Consciousness
NCT03115021
completednot_applicable
Neurophysiological Effects on tPCS and tDCS on Healthy Subjects and on Patients With Chronic Visceral Pain
NCT02497196
unknownnot_applicable
A Trial of tPCS on Parkinson's Disease OFF State
NCT04054960
Clinical Trials (3)
Showing 3 of 3 trials
NCT03115021Phase 1
Neurophysiological Effects of tPCS and tDCS on Patients With Disorders of Consciousness
NCT02497196Not Applicable
Neurophysiological Effects on tPCS and tDCS on Healthy Subjects and on Patients With Chronic Visceral Pain
NCT04054960Not Applicable
A Trial of tPCS on Parkinson's Disease OFF State
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3